These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27595035)

  • 1. High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.
    Hauser N; Sahai T; Richards R; Roberts T
    Case Rep Transplant; 2016; 2016():4028492. PubMed ID: 27595035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.
    Formea CM; Evans CG; Karlix JL
    Pharmacotherapy; 2005 Jul; 25(7):1021-9. PubMed ID: 16006281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytochrome P450 3A polymorphism and its importance in cyclosporine and tacrolimus therapy in transplanted patients].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2007 Oct; 56(5):220-4. PubMed ID: 18064802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana".
    Hauser N; Sahai T; Richards R; Roberts T
    Case Rep Transplant; 2018; 2018():7095846. PubMed ID: 30258665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors.
    Yano I
    Drug Metab Pharmacokinet; 2008; 23(3):150-7. PubMed ID: 18574318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of clinically relevant drug interactions associated with tacrolimus.
    Christians U; Jacobsen W; Benet LZ; Lampen A
    Clin Pharmacokinet; 2002; 41(11):813-51. PubMed ID: 12190331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors.
    Utecht KN; Hiles JJ; Kolesar J
    Am J Health Syst Pharm; 2006 Dec; 63(23):2340-8. PubMed ID: 17106006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus for the prevention and treatment of rejection of solid organ transplants.
    Scalea JR; Levi ST; Ally W; Brayman KL
    Expert Rev Clin Immunol; 2016; 12(3):333-42. PubMed ID: 26588770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report.
    Malireddy SR; Pinto AG; Chalasani NP; Gorski JC; Hall SD
    Transplant Proc; 2008 Jun; 40(5):1789-91. PubMed ID: 18589198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
    Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
    Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.
    Onizuka M; Kunii N; Toyosaki M; Machida S; Ohgiya D; Ogawa Y; Kawada H; Inoko H; Ando K
    Bone Marrow Transplant; 2011 Aug; 46(8):1113-7. PubMed ID: 21102498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
    Staatz CE; Tett SE
    Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus.
    Goklemez S; Curtis LM; Hawwa A; Ling A; Avila D; Heller T; Pavletic SZ
    Mayo Clin Proc Innov Qual Outcomes; 2017 Sep; 1(2):198-201. PubMed ID: 30225417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has the "M" word been framed? Marijuana, cannabis, and public opinion.
    Mikos RA; Kam CD
    PLoS One; 2019; 14(10):e0224289. PubMed ID: 31671110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions with tacrolimus.
    van Gelder T
    Drug Saf; 2002; 25(10):707-12. PubMed ID: 12167066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clotrimazole troches induce supratherapeutic blood levels of sirolimus and tacrolimus in an allogeneic hematopoietic cell-transplant recipient resulting in acute kidney injury.
    El-Asmar J; Gonzalez R; Bookout R; Mishra A; Kharfan-Dabaja MA
    Hematol Oncol Stem Cell Ther; 2016 Dec; 9(4):157-161. PubMed ID: 26684920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.